The antibody-complement system required for immune hemolysis has been studied extensively and is being defined rapidly (1-5). The effect of antibody and complement (C t) on the red blood cell recently assumed a dramatic morphological perspective when it was demonstrated that discrete holes or lesions were produced on the erythrocyte cell membrane during immune hemolysis (6).Lysis and inhibition of growth of Gram-negative bacteria by mammalian serum can also be mediated by antibody and C' (7,8). However, little is known about the mechanism of this reaction. In general, it is thought that the actual killing and lysis of the bacterial cell results from the effect(s) of C' and lysozyme (9, 10). It was suggested that C' action upon the lipoprotein layer of the cell membrane results in perforations of the cell surface, facilitating the access of lysozyme to its mucopeptide substrate. These events were postulated to culminate in lysis of the bacterial cell. Recently one step in this reaction, the presence of perforations or lesions after action of antibody and C', was demonstrated on spheroplasts of Esckerickia coli (11). Mediation of these lesions by C' implied a possible similarity to the mechanism of action involved in the formation of lesions on erythrocytes. However, it was not established which membranes were affected by C ~, nor were the conditions necessary for this C rmediated effect determined. In this report, attention is directed toward another Gram-negative genus, Veillonella, whose cell surface layers can be clearly differentiated by electron microscopy (12). The interaction of serum C ~ and the somatic endotoxic lipopolysaccharide of Veillonella alcalescens was investigated. The results clearly demonstrate that the lipopolysaccharide complex, as contained in the outer three-layer membrane of the cell (12), serves as a substrate for the action of serum C t. The results further suggest that in their reaction with lipopolysaccharide, the C t components go through a sequence of interactions similar to that required for immune hemolysis. 767 on